Category: Astrazeneca

Pfizer Increases Spring Vaccine Schedule, Adds Five Million Doses to June Shipments

OTTAWA—Canada’s promised spring supply of COVID-19 vaccines grew Tuesday with millions of additional doses now expected to arrive from three different suppliers before Canada Day. But the news was tempered by ongoing concerns about the Oxford-AstraZeneca vaccine, and signs in much of the country that the pandemic still has a lot more misery to unleash….


Berlin State Hospitals Pause AstraZeneca Shots for Women Staff Under 55

BERLIN—Berlin’s state hospital groups Charite and Vivantes have stopped giving women under the age of 55 shots of AstraZeneca’s COVID-19 vaccine, spokeswomen for the hospitals said on Tuesday. The moves follow reports of rare but serious blood clots, bleeding, and in some cases death after vaccination, mainly in young women. “From the Charité’s point of…


Canada Pauses AstraZeneca Vaccine for Under 55

TORONTO—Canada on Monday suspended the use of the Oxford-AstraZeneca coronavirus vaccine for people under age 55 following concerns it might be linked to rare blood clots. The National Advisory Committee on Immunization had recommended the pause for safety reasons and the Canadian provinces, which administer health in the country, announced the suspension Monday. “There is…


Germany Reports More Blood Clot Cases Associated With AstraZeneca Vaccine

Germany’s health department reported an additional 21 people who recently received the AstraZeneca coronavirus vaccine suffered blood clots, The Associated Press reported. Seven of the people who had blood clots have died, the Paul Ehrlich Institute, which is Germany’s federal medical regulatory body, told The Associated Press. Nineteen of the individuals affected by the blood…


EU Turns up Heat on AstraZeneca as New COVID-19 Wave Surges

BRUSSELS—EU leaders voiced frustration on Thursday over a massive shortfall in contracted deliveries of AstraZeneca COVID-19 vaccines, as a third wave of infections surged across Europe. With inoculation programs running far behind those of Britain and the United States, the bloc’s executive warned that vaccine exports by the British-Swedish company would be blocked until it…


Norway Keeps AstraZeneca Vaccine on Hold for Another Three Weeks

OSLO—Norway will delay its decision on whether to resume the use of AstraZeneca’s COVID-19 vaccine by up to three weeks, the Norwegian Institute of Public Health (FHI) said on Friday. Authorities on March 11 suspended the rollout of the vaccine after a small number of younger inoculated people were hospitalized for a combination of blood…


AstraZeneca’s Revised COVID-19 Vaccine Data Shows Slight Dip in Efficacy

AstraZeneca on Wednesday released an updated estimate showing a slight dip in the efficacy of its COVID-19 vaccine.


EU to Extend Vaccine Export Curbs to Cover Britain, Backloading: Source

BRUSSELS—The European Commission on Wednesday will extend EU powers to potentially block COVID-19 vaccine exports to Britain and other areas with much higher vaccination rates, and to cover instances of companies backloading contracted supplies, EU officials said. The regulation is aimed at making vaccine trade reciprocal and proportional so that other vaccine-making countries sell to…


AstraZeneca May Have Used Outdated Information in COVID-19 Vaccine Trial: US

Results from a U.S. clinical trial testing the efficacy and safety of AstraZeneca’s COVID-19 vaccine may have included “outdated information,” American officials said early Tuesday. The Data Safety Monitoring Board notified the company and two health agencies late Monday that it was worried by the information AstraZeneca released on its trial. The board, which monitors…


As Vaccine Battle With UK Deepens, EU Blames AstraZeneca

LONDON—Britain on Monday demanded the European Union allow the delivery of COVID-19 vaccines it has ordered as tensions over a possible export ban on EU-manufactured shots mounted and Brussels pointed an accusing finger at drugmaker AstraZeneca. “The UK is not to blame. The EU is not to blame,” said an EU official. “It’s about everyone…